Sangamo BioSciences | SGMO - Ebitda





Ebitda تغيير تاريخ
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
Amgen USD 5.14B 775M 2025-12
Bayer EUR 1.97B 457M 2025-12
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Biogen USD 573.2M 253.7M 2025-12
BioMarin Pharmaceutical USD -24.17M 18.91M 2025-12
Cipla INR 12.55B 6.4B 2025-12
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -7.89M 536K 2025-09
CSL USD 3.13B 1.17B 2025-12
Gilead Sciences USD 4.03B 628M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
Grifols EUR 482.04M 7.04M 2025-09
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
J&J USD 9.52B 389M 2025-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Merck USD 8.39B 1.97B 2025-09
Novartis USD 4.77B 1.11B 2025-12
Omeros USD -47.96M 7.39M 2023-09
Pfizer USD 6.08B 351M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 4.84B 2.95B 2025-09
Sarepta Therapeutics USD -168.03M 294.45M 2025-09
Tectonic Therapeutic USD -21.18M 365K 2025-12
Ultragenyx Pharmaceutical USD -156.79M 65.44M 2025-09
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09